77 related articles for article (PubMed ID: 24733189)
21. KCa3.1: a new player in progressive kidney disease.
Huang C; Pollock CA; Chen XM
Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):61-6. PubMed ID: 25415613
[TBL] [Abstract][Full Text] [Related]
22. Role of the potassium channel KCa3.1 in diabetic nephropathy.
Huang C; Pollock CA; Chen XM
Clin Sci (Lond); 2014 Oct; 127(7):423-33. PubMed ID: 24963668
[TBL] [Abstract][Full Text] [Related]
23. High glucose induces CCL20 in proximal tubular cells via activation of the KCa3.1 channel.
Huang C; Pollock CA; Chen XM
PLoS One; 2014; 9(4):e95173. PubMed ID: 24733189
[TBL] [Abstract][Full Text] [Related]
24. KCa3.1 mediates dysfunction of tubular autophagy in diabetic kidneys via PI3k/Akt/mTOR signaling pathways.
Huang C; Lin MZ; Cheng D; Braet F; Pollock CA; Chen XM
Sci Rep; 2016 Mar; 6():23884. PubMed ID: 27029904
[TBL] [Abstract][Full Text] [Related]
25. The KCa3.1 blocker TRAM34 reverses renal damage in a mouse model of established diabetic nephropathy.
Huang C; Zhang L; Shi Y; Yi H; Zhao Y; Chen J; Pollock CA; Chen XM
PLoS One; 2018; 13(2):e0192800. PubMed ID: 29425253
[TBL] [Abstract][Full Text] [Related]
26. Thioredoxin-interacting protein mediates dysfunction of tubular autophagy in diabetic kidneys through inhibiting autophagic flux.
Huang C; Lin MZ; Cheng D; Braet F; Pollock CA; Chen XM
Lab Invest; 2014 Mar; 94(3):309-20. PubMed ID: 24492284
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of KCa3.1 suppresses TGF-β1 induced MCP-1 expression in human proximal tubular cells through Smad3, p38 and ERK1/2 signaling pathways.
Huang C; Day ML; Poronnik P; Pollock CA; Chen XM
Int J Biochem Cell Biol; 2014 Feb; 47():1-10. PubMed ID: 24291552
[TBL] [Abstract][Full Text] [Related]
28. KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis.
Huang C; Shen S; Ma Q; Gill A; Pollock CA; Chen XM
Nephrol Dial Transplant; 2014 Feb; 29(2):313-24. PubMed ID: 24166472
[TBL] [Abstract][Full Text] [Related]
29. Blockade of KCa3.1 ameliorates renal fibrosis through the TGF-β1/Smad pathway in diabetic mice.
Huang C; Shen S; Ma Q; Chen J; Gill A; Pollock CA; Chen XM
Diabetes; 2013 Aug; 62(8):2923-34. PubMed ID: 23656889
[TBL] [Abstract][Full Text] [Related]
30. Role of KCa3.1 channels in proliferation and migration of vascular smooth muscle cells by diabetic rat serum.
Su XL; Zhang H; Yu W; Wang S; Zhu WJ
Chin J Physiol; 2013 Jun; 56(3):155-62. PubMed ID: 23656217
[TBL] [Abstract][Full Text] [Related]
31. Macrophages in renal disease.
Wang Y; Harris DC
J Am Soc Nephrol; 2011 Jan; 22(1):21-7. PubMed ID: 21209251
[TBL] [Abstract][Full Text] [Related]
32. Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice.
Doi S; Zou Y; Togao O; Pastor JV; John GB; Wang L; Shiizaki K; Gotschall R; Schiavi S; Yorioka N; Takahashi M; Boothman DA; Kuro-O M
J Biol Chem; 2011 Mar; 286(10):8655-8665. PubMed ID: 21209102
[TBL] [Abstract][Full Text] [Related]
33. The roles of Kruppel-like factor 6 and peroxisome proliferator-activated receptor-γ in the regulation of macrophage inflammatory protein-3α at early onset of diabetes.
Qi W; Holian J; Tan CY; Kelly DJ; Chen XM; Pollock CA
Int J Biochem Cell Biol; 2011 Mar; 43(3):383-92. PubMed ID: 21109018
[TBL] [Abstract][Full Text] [Related]
34. NF-kappaB in renal inflammation.
Sanz AB; Sanchez-Niño MD; Ramos AM; Moreno JA; Santamaria B; Ruiz-Ortega M; Egido J; Ortiz A
J Am Soc Nephrol; 2010 Aug; 21(8):1254-62. PubMed ID: 20651166
[TBL] [Abstract][Full Text] [Related]
35. Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts.
Liu RM; Choi J; Wu JH; Gaston Pravia KA; Lewis KM; Brand JD; Mochel NS; Krzywanski DM; Lambeth JD; Hagood JS; Forman HJ; Thannickal VJ; Postlethwait EM
J Biol Chem; 2010 May; 285(21):16239-47. PubMed ID: 20228065
[TBL] [Abstract][Full Text] [Related]
36. Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease.
Köhler R; Kaistha BP; Wulff H
Expert Opin Ther Targets; 2010 Feb; 14(2):143-55. PubMed ID: 20055714
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
